Petros Pharmaceuticals, Inc. (PTPI) Financials

PTPI Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 38.9 million 31.9 million
June 30, 2023 28.7 million 15.8 million
March 31, 2023 30.6 million 15.1 million
Dec. 31, 2022 32.4 million 15.7 million

PTPI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -3.7 million 30840
June 30, 2023 -572070 43316
March 31, 2023 -748363 130336
Dec. 31, 2022 -1.6 million 228845

PTPI Net Income

No data available :(

PTPI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 18.0 million - 300153
June 30, 2023 7.4 million - 183328
March 31, 2023 8.3 million - 223575
Dec. 31, 2022 9.4 million - 262678

PTPI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 2.1 million
June 30, 2023 2.1 million
March 31, 2023 2.1 million
Dec. 31, 2022 2.1 million

PTPI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 389093 2.0 million -
June 30, 2023 - 866575 2.2 million -
March 31, 2023 - 319093 2.1 million -
Dec. 31, 2022 - 177762 2.9 million -

PTPI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 1.7 million 408475
June 30, 2023 2.0 million 513857
March 31, 2023 2.5 million 550742
Dec. 31, 2022 798101 881332

PTPI

Price: $0.01

52 week price:
0.00
0.21

Earnings Per Share: -29.01 USD

P/E Ratio: -0.02

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 7800

Market Capitalization: 196309

Links: